Literature DB >> 10618437

Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system.

M Glatzel1, E Flechsig, B Navarro, M A Klein, J C Paterna, H Büeler, A Aguzzi.   

Abstract

Targeted expression of foreign genes to the peripheral nervous system is interesting for many applications, including gene therapy of neuromuscular diseases, neuroanatomical studies, and elucidation of mechanisms of axonal flow. Here we describe a microneurosurgical technique for injection of replication-defective viral vectors into dorsal root ganglia (DRG). Adenovirus- and adeno-associated virus-based vectors with transcriptional competence for DRG neurons led to expression of the gene of interest throughout the first neuron of the sensory system, from the distal portions of the respective sensory nerve to the ipsilateral nucleus gracilis and cuneatus, which contains the synapses to the spinothalamic tracts. Use of Rag-1 ablated mice, which lack all B and T lymphocytes, allowed for sustained expression for periods exceeding 100 days. In immunocompetent mice, long-term (52 days) expression was achieved with similar efficiency by using adeno-associated viral vectors. DRG injection was vastly superior to intraneural injection into the sciatic nerve, which mainly transduced Schwann cells in the vicinity of the site of inoculation site but only inefficiently transduced nerve fibers, whereas i.m. injection did not lead to any significant expression of the reporter gene in nerve fibers. The versatile and efficient transduction of genes of interest should enable a wide variety of functional studies of peripheral nervous system pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618437      PMCID: PMC26682          DOI: 10.1073/pnas.97.1.442

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Spread of scrapie agent to the central nervous system: study of a rat model.

Authors:  M H Bassant; H Baron; M Gumpel; F Cathala; L Court
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

2.  Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor.

Authors:  B J Baumgartner; H D Shine
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

3.  Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection.

Authors:  G N Fuller; J M Jacobs; R J Guiloff
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

5.  Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

Authors:  J E Donello; J E Loeb; T J Hope
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

8.  Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action.

Authors:  G Haase; B Pettmann; E Vigne; L Castelnau-Ptakhine; H Schmalbruch; A Kahn
Journal:  J Neurol Sci       Date:  1998-10       Impact factor: 3.181

9.  Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver.

Authors:  H G Zhang; T Zhou; P Yang; C K Edwards; D T Curiel; J D Mountz
Journal:  Hum Gene Ther       Date:  1998-09-01       Impact factor: 5.695

10.  Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha.

Authors:  K Benihoud; I Saggio; P Opolon; B Salone; F Amiot; E Connault; C Chianale; F Dautry; P Yeh; M Perricaudet
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  37 in total

1.  Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.

Authors:  Y Xu; Y Gu; G-Y Xu; P Wu; G-W Li; L-Y M Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Lentiviral vector mediates exogenous gene expression in adult rat DRG following peripheral nerve remote delivery.

Authors:  Ping Yang
Journal:  J Mol Neurosci       Date:  2012-02-09       Impact factor: 3.444

Review 3.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

4.  AAV provides an alternative for gene therapy of the peripheral sensory nervous system.

Authors:  Andreas S Beutler
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

5.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 6.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

Review 7.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

8.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

9.  DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.

Authors:  Tomoya Terashima; Kazuhiro Oka; Angelika B Kritz; Hideto Kojima; Andrew H Baker; Lawrence Chan
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  AAV-Mediated Gene Transfer to Dorsal Root Ganglion.

Authors:  Hongwei Yu; Gregory Fischer; Quinn H Hogan
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.